论文部分内容阅读
起搏是心房颤动（Ａｆ）治疗学的一个进展。为此，本文综述了房颤病人常见与少见的起搏指征，并提出房颤病人起搏的优选形式：慢性房颤应选用频率调节起搏（ＶＶＩ或ＶＶＩＲ）；阵发性房颤应以双腔起搏（ＤＤＤ或ＤＤＩ）为优选。此外，起搏也可用于预防阵发性房颤的发生。抗心律失常药物对接受起搏的病人可产生不同影响，特别是Ｉ＿Ａ和Ｉ＿Ｃ类药物可消极影响起搏效能，需行起搏治疗者不宜使用此二类药物。安装永久性起搏器的病人还可行心脏电转复治疗，但需采取必要措施，以防临床恶化或损坏起搏器。
Pacing is a progression of atrial fibrillation (Af) therapies. To this end, this article reviews the common and rare indications of pacing in patients with atrial fibrillation and presents the preferred form of pacing in patients with atrial fibrillation: frequency-adjusted pacing (VVI or VVIR) should be used for chronic atrial fibrillation; paroxysmal atrial fibrillation Dual-chamber pacing (DDD or DDI) is preferred. In addition, pacing can also be used to prevent the occurrence of paroxysmal atrial fibrillation. Antiarrhythmic drugs can have different effects on pacing patients, especially I_A and I_C, which can negatively affect pacing performance and should not be used with pacing therapy. Patients with permanent pacemakers are also eligible for cardioverter rehabilitation, but necessary steps must be taken to prevent clinical deterioration or damage to the pacemaker.